Quantcast

Latest Colorectal cancer Stories

2014-09-30 12:30:21

COPENHAGEN, Denmark, Sept. 30, 2014 /PRNewswire/ -- DanDrit Biotech A/S ("DanDrit Denmark"), the subsidiary of DanDrit Biotech USA, Inc. ("DanDrit"), a biotechnology company seeking to develop an approved vaccine for the treatment of colorectal cancer, signed a contract of collaboration with the University Hospital IRCCS "San Martino" - IST - National Institute for Cancer Research known as the San Martino Hospital of Genoa. Dr. Alberto Sobrero, the Head of the Medical Oncology Unit at...

2014-09-29 12:28:40

ALBANY, New York, September 29, 2014 /PRNewswire/ -- According to a new market report published by Transparency Market Research "Circulating Circulating Tumor Cells (CTCs) Prognostic Technologies Market [Technologies: Tumor Cell Enrichment (Filtration, Centrifugation and Immunological & Immunomagnetic Methods) & Tumor Cell Detection (Molecular Methods and Optical Methods) and Applications: Prostate Cancer, Breast Cancer, Colorectal Cancer and Others] - Global Industry...

2014-09-29 08:30:18

BONN, Germany, September 29, 2014 /PRNewswire/ -- Newly published European Society for Medical Oncology (ESMO) clinical guidelines for the treatment of metastatic colorectal cancer (mCRC) endorse radioembolisation, specifically with Yttrium-90 resin microspheres, as a clinically proven technology to "prolong time to liver tumour progression" in mCRC patients who have failed to respond to available chemotherapy options. SIR-Spheres Y-90 resin microspheres, the lead...

2014-09-24 16:25:48

Bipartisan committee forms to provide expertise, advice and guidance in establishing legislative priorities for Fight Colorectal Cancer. ALEXANDRIA, Va., Sept. 24, 2014 /PRNewswire-iReach/ -- Today Fight Colorectal Cancer announced the establishment of the Fight Colorectal Cancer Congressional Advisory Committee. Reps. Donald M. Payne, Jr. (D-NJ), Charlie Dent (R-PA), Mike Fitzpatrick (R-PA) and Leonard Lance (R-NJ) will serve as inaugural members and advise Fight Colorectal Cancer...

2014-09-22 16:29:05

MELBOURNE, Australia, Sept. 22, 2014 /PRNewswire/ -- Propanc Health Group Corporation (OTCQB: PPCH) ("Propanc" or "the Company"), an emerging healthcare company that focuses on the development of new and proprietary treatments for cancer patients, is pleased to announce it has executed an equity purchase agreement (the "EPA") with Southridge Partners II, L.P., an institutional investor, in the amount of $5 million, which will create significant growth capital for Propanc, enabling the...

2014-09-14 23:00:36

A study led by University of Colorado Cancer Center published today in the journal Nature uses a novel approach to target the activation of a protein that drives some cancers. AURORA, Colo. (PRWEB) September 14, 2014 When active, the protein called Ral can drive tumor growth and metastasis in several human cancers including pancreatic, prostate, lung, colon and bladder. Unfortunately, drugs that block its activity are not available. A study published today in the journal Nature uses a...

2014-09-11 16:28:16

QUEBEC CITY, Sept. 11, 2014 /PRNewswire/ - DiagnoCure, Inc. (TSX: CUR) (OTCQX: DGCRF) (the "Corporation") today reported financial and operational results for the third quarter 2014 ended July 31, 2014. The Corporation announced a net loss of $504,105 or $0.01 per share for this quarter compared with a loss of $595,262 or $0.01 per share for the same period last year. During the third quarter ended July 31, 2014, total revenues decreased by 19% compared with the same quarter of 2013, due to...

2014-09-10 08:31:01

MINNEAPOLIS, Sept. 10, 2014 /PRNewswire/ -- The ENDOCUFF(TM) Endoscopic Overtube now provided by MEDIVATORS, a leading medical device company with over thirty years of experience in endoscopy technology, substantially improves adenoma and polyp detection during colonoscopies according to two separate industry studies. The ENDOCUFF device is a small disposable plastic over-tube with soft flexible projections. Placed over the tip of the endoscope, the device helps increase control and...

2014-09-08 08:31:27

SAN DIEGO and PRINCETON, N.J., Sept. 8, 2014 /PRNewswire/ -- Aethlon Medical, Inc. (NASDAQ:OTCQB:AEMD), and its diagnostic subsidiary, Exosome Sciences, Inc. (ESI), announced today that ESI researchers have developed and initially validated a lectin-based diagnostic platform that is able to isolate exosome-based biomarkers underlying a broad-spectrum of oncology indications. Aethlon Medical develops targeted therapeutic devices to address infectious disease, cancer and other...

2014-08-28 12:30:01

Introduction of Extended RAS Testing and Recent Clinical Trial Data Will Affect How Physicians Treat Colorectal Cancer Patients, According to Findings from Decision Resources Group BURLINGTON, Mass., Aug. 28, 2014 /PRNewswire/ -- Decision Resources Group finds that the market for colorectal cancer (CRC) therapies will remain constant, at around $7.7 billion by 2023 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan. The biosimilar erosion of...


Latest Colorectal cancer Reference Libraries

Sigmoidoscopy
2013-03-04 10:30:47

Sigmoidoscopy is a medical procedure in which the physician is able to visualize the inside walls of the large intestine with a scope placed in the rectum. Only the distal part of the colon, or the sigmoid, is examined as opposed to the entire bowel in a colonoscopy. Reasons for procedure The use of this procedure is mainly for early detection of colorectal cancer, vascular abnormalities or polyps. Studies have shown that this procedure has aided in early detection of colorectal cancer...

More Articles (1 articles) »
Word of the Day
caparison
  • A cloth or covering, more or less ornamented, laid over the saddle or furniture of a horse, especially of a sumpter-horse or horse of state.
  • Clothing, especially sumptuous clothing; equipment; outfit.
  • To cover with a caparison, as a horse.
  • To dress sumptuously; adorn with rich dress.
This word ultimately comes from the Medieval Latin 'cappa,' cloak.
Related